Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665357 | SCV000789467 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2017-02-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733826 | SCV000861926 | pathogenic | not provided | 2018-06-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000665357 | SCV002236711 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2021-08-09 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 550578). This premature translational stop signal has been observed in individual(s) with autosomal recessive CAPN3-related conditions (PMID: 7720071). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp360*) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). |